270 related articles for article (PubMed ID: 19816675)
21. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
[TBL] [Abstract][Full Text] [Related]
22. Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway?
Biggs CS; Fowler LJ; Whitton PS; Starr MS
Brain Res; 1997 Apr; 753(1):163-75. PubMed ID: 9125444
[TBL] [Abstract][Full Text] [Related]
23. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
24. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
25. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
Unterwald EM; Cuntapay M
Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003
[TBL] [Abstract][Full Text] [Related]
26. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
Ferré S; Giménez-Llort L; Artigas F; Martínez E
Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
[TBL] [Abstract][Full Text] [Related]
27. Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex.
Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
Eur J Neurosci; 2003 Feb; 17(4):763-70. PubMed ID: 12603266
[TBL] [Abstract][Full Text] [Related]
28. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
29. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
30. Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression.
Gross NB; Marshall JF
Neuroscience; 2009 Jul; 161(4):1114-25. PubMed ID: 19374938
[TBL] [Abstract][Full Text] [Related]
31. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
Campos F; Alfonso M; Vidal L; Faro LR; Durán R
Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020
[TBL] [Abstract][Full Text] [Related]
32. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors.
Hu XT; White FJ
Neurosci Lett; 1997 Mar; 224(1):61-5. PubMed ID: 9132692
[TBL] [Abstract][Full Text] [Related]
33. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
34. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum.
Izquierdo-Claros RM; Boyano-Adánez MC; Larsson C; Gustavsson L; Arilla E
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):99-107. PubMed ID: 9221906
[TBL] [Abstract][Full Text] [Related]
35. Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.
Daigle TL; Wetsel WC; Caron MG
Eur J Neurosci; 2011 Nov; 34(9):1378-89. PubMed ID: 22034973
[TBL] [Abstract][Full Text] [Related]
36. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
[TBL] [Abstract][Full Text] [Related]
37. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms.
West AR; Galloway MP
Neuropharmacology; 1997; 36(11-12):1571-81. PubMed ID: 9517428
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
[TBL] [Abstract][Full Text] [Related]
39. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
40. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Paul ML; Graybiel AM; David JC; Robertson HA
J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
